Global Next-Generation Sequencing Market Assessment, By Product [NGS Consumables, Presequencing Products and Services, Sequencing Services, NGS Platforms, Bioinformatics, Services for NGS Platforms], By Sequencing Type [RNA Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Targeted Resequencing, CHIP Sequencing, De Novo Sequencing, Methyl Sequencing, Others], By Technology [Sequencing by Synthesis, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Ion Semiconductor Sequencing, Others], By Application [Drug Discovery and Personalized Medicine, Diagnostics, Genetic Screening, Agriculture and Animal Research, Others], By End-user [Hospitals and Clinics, Academic Institutes and Research Centers, Pharmaceutical and Biotechnology Companies, Others], By Region, Opportunities and Forecast, 2017-2031F
Global next-generation sequencing market is being influenced by heightened usage in clinical diagnostics, rising instances of cancer, crucial technological advancements, and reducing costs of genome sequencing.
Home>Industry Reports>Global Next-Generation Sequencing Market Assessment, Opportunities and Forecast, 2017-2031F
Global next-generation sequencing market is projected to witness a CAGR of 17.52% during the forecast period 2024-2031, growing from USD 10.59 billion in 2023 to USD 38.52 billion in 2031. Various elements have propelled the growth and expansion of the global next-generation sequencing market. Key factors encompass the reduction in costs, increased applications in clinical diagnostics, advancements in technology, expanding research activities, collaborative partnerships, broader uses in agriculture and animal genomics, rising demand for personalized medicine, supportive government initiatives and funding, and the escalating awareness and acceptance of NGS technologies.
In line with this, the continual decrease in sequencing expenses has notably broadened accessibility, allowing researchers and clinicians to utilize NGS across various disciplines. Simultaneously, the upsurge in NGS applications in clinical diagnostics has been transformative, harnessing its capabilities for disease identification, treatment planning, and the realm of personalized medicine, consequently enhancing its importance in healthcare. The cornerstone of advancements in sequencing technologies has consistently improved precision, speed, and cost-effectiveness, thereby increasing NGS's appeal across diverse industries and propelling the growth of global next-generation sequencing market. This momentum has been further driven by the proliferation of academic, pharmaceutical, and biotechnological research undertakings, enabling a more profound exploration of genomics and its practical applications.
Synergistic collaborations and partnerships within the global next-generation sequencing market have spurred innovation, propelling product enhancements and broadening the spectrum of NGS applications. Furthermore, the integration of NGS in agricultural and animal genomics has revolutionized practices related to crop enhancement, breeding programs, and disease analysis, extending its utility beyond human healthcare. The escalating demand for personalized medicine has emerged as a pivotal driver, harnessing NGS's capability to decipher individual genetic variations for tailor-made treatments. Supportive government initiatives and funding have incentivized research, advancement, and the widespread adoption of NGS technologies. Ultimately, the growing awareness and acceptance of NGS within the scientific community and among the general population have bolstered its significance, solidifying its pivotal role as an indispensable instrument for innovation and progress across the global next-generation sequencing market.
Increased Applications in Clinical Diagnostics
The significant increase in clinical diagnostics applications serves as a fundamental driver advancing the global next-generation sequencing market. This surge originates from NGS's transformative capabilities in identifying diseases, predicting their progression, and tailoring treatment plans. Through comprehensive genomic profiling, NGS aids in detecting disease-related genetic variations, improving diagnostic accuracy and refining treatment decisions. Its versatility spans across oncology, inherited conditions, infectious diseases, and pharmacogenomics, offering in-depth insights into individual genetic profiles. Furthermore, the ongoing enhancement of NGS technologies has diminished expenses and enhanced effectiveness, rendering it more feasible for regular clinical utilization. Consequently, the incorporation of NGS into clinical routines is expanding, catalysing a shift towards precision medicine. This amplified adoption in clinical environments not only elevates patient care standards but also propels the upward trajectory of the global NGS market, emphasizing its substantial impact on contemporary healthcare practices.
Technological Advancements
Technological advancements, notably Artificial Intelligence (AI), are potent catalysts propelling the global next-generation sequencing market forward. AI integration augments NGS by streamlining data analysis, enhancing accuracy, and expediting insights from complex genomic information. Machine learning algorithms assist in interpreting vast sequencing datasets, facilitating the identification of genetic patterns linked to diseases or therapeutic responses. This convergence of AI with NGS amplifies efficiency, reduces costs, and enables innovative applications, extending the technology's appeal across research, clinical diagnostics, and personalized medicine. Such advancements are pivotal in shaping the landscape of genomics and its widespread utilization, underscoring AI's crucial role in advancing the NGS domain.
For instance, in July 2023, South Korea's NGeneBio Co., a medical diagnostics firm, revealed the creation of "NGeneBioAI," an AI-driven precision diagnostic company in the United States. Fully financed by its parent company, NGeneBio, this venture is poised to significantly impact the US cancer diagnostics market. Leveraging its next-generation sequencing (NGS) precision diagnostic platform, NGeneBioAI aims to establish a pivotal presence in the realm of cancer diagnostics within the United States.
Government Initiatives
Governments across the globe are employing varied approaches, notably promoting collaborations between the public and private sectors, to strengthen the global next-generation sequencing market. These strategies aim to merge governmental resources with the expertise of private entities, fostering cooperation in technological advancements, genomics research, and innovative practices. Through these partnerships, governments facilitate knowledge exchange, funding accessibility and the establishment of supportive structures, hastening the uptake and advancement of NGS technologies. These coordinated endeavors leverage the strengths of both sectors, driving the expansion of the NGS market and securing its pivotal role in propelling worldwide scientific advancements and progress in healthcare.
For instance, in October 2023, The Department of Health and Human Services disclosed awards exceeding USD 500 million to aid companies advancing their vaccine candidates into Phase 2b clinical trials and innovating new technologies within Project NextGen. This initiative, a USD 5 billion government endeavour, aims to accelerate the development of next-gen vaccines and treatments via collaborations between public and private entities. The funding supports efforts to expedite vaccine development and the exploration of cutting-edge technologies, reflecting Project NextGen's commitment to catalysing advancements in the medical field through strategic partnerships.
Growing Demand for RNA Sequencing Tools
The surging desire for RNA sequencing tools is crucial in propelling the global next-generation sequencing market. This increased requirement stems from the pivotal function of RNA sequencing in interpreting gene expression, investigating transcriptomic patterns, and comprehending RNA-based mechanisms within health and disease contexts. RNA sequencing empowers the examination of various RNA molecules, enabling the elucidation of complex biological processes, discovery of biomarkers, and identification of therapeutic targets. As the scientific community increasingly acknowledges RNA's importance, the rising demand for RNA sequencing tools drives innovation in NGS technologies, significantly contributing to market expansion and advancing biological research and clinical applications.
As an example, in May 2023, Twist Bioscience Corporation—a business that empowers clients to thrive by providing premium synthetic DNA via its silicon platform—announced the introduction of a range of RNA sequencing instruments, comprising the Twist RNA Exome, Twist RNA Library Prep Kit, and the Twist Ribosomal RNA (rRNA) & Haemoglobin (Globin) Depletion Kit, in addition to customized target enrichment capabilities for RNA and whole transcriptome sequencing.
Growing Popularity of Next-Generation Sequencing Service
The increasing need for advanced sequencing services drives the global next-generation sequencing market. NGS transforms genomics, facilitating swift, cost-efficient DNA sequencing. Its wide-ranging applications in healthcare, agriculture, and research propel market growth. Heightened occurrences of genetic disorders, personalized medicine trends, and bioinformatics advancements boost NGS demand. Moreover, reduced sequencing expenses enhance its accessibility. Industries and research bodies increasingly embrace NGS due to its high-throughput capabilities and precise data, fostering market expansion. This surge in demand sustains the continual upward trajectory of the global next generation sequencing market, meeting the diverse needs across various fields seeking comprehensive genomic insights.
For instance, in August 2023, Quantum-Si, a company specializing in protein sequencing, introduced a groundbreaking Next-Generation Protein Sequencing Platform. This innovative Platinum platform, the first of its kind, offers a straightforward, user-friendly benchtop solution that seamlessly fits into current workflows. It aims to enable laboratories worldwide to perform benchtop proteomics experiments easily and effectively.
Future Market Scenario (2024-2031F)
The future of the global next-generation sequencing market holds immense promise, driven by technological progress like enhanced automation, precision, and cost reduction. NGS's adaptability spans diverse domains like healthcare, agriculture, and scientific research, amplifying its importance. Rising genetic-based treatments and diagnostics, alongside a surging demand for personalized medicine, heighten NGS's relevance in healthcare. Moreover, its application in agricultural genomics signals potential for improved crop productivity and sustainability.
Ongoing innovations in bioinformatics and data analysis refine NGS capabilities, uncovering deeper genetic insights. Advancements toward point-of-care sequencing and potential integration with AI foreshadow a future of more accessible and efficient genomic analysis. Despite challenges like data management and ethical concerns, persistent research, partnerships, and regulatory backing maintain an optimistic market trajectory. Consequently, the global NGS market appears poised for sustained growth and transformative advancements, reflecting a bright and promising future.
Report Scope
“Next-Generation Sequencing Market Assessment, Opportunities, and Forecast, 2017-2031F”, is a comprehensive report by Markets and data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the global next-generation sequencing market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, future market scenario, opportunities, and forecast between 2024 and 2031. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.
|
Report Attribute |
Details |
|
Base Year of the Analysis |
2023 |
|
Historical Period |
2017-2022 |
|
Forecast Period |
2024-2031 |
|
Projected Growth Rate |
CAGR of 17.52% between 2024-2031 |
|
Revenue Forecast in 2031 |
USD 38.52 billion |
|
Segments Covered |
Product, Sequencing, Technology, Application, End-user |
|
Regions Covered |
North America, South America, Europe, Asia-Pacific, Middle East and Africa |
|
Key Companies Profiled |
Illumina Inc., Thermo Fisher Scientific Inc., BGI Group, Agilent Technologies, Inc., Qiagen N.V., Macrogen, Inc., Pacific Biosciences of California, Inc., Genewiz, LLC, 10x Genomics, Inc., Oxford Nanopore Technologies plc, F. Hoffmann-La Roche AG |
|
Customization Scope |
15% free report customization with purchase |
|
Pricing and Purchase Options |
Avail the customized purchase options to fulfil your precise research needs |
|
Delivery Format |
PDF and Excel through email (subject to the license purchased) |
In this report, global next-generation sequencing market has been segmented into the following categories:
· By Product
o NGS Consumables
o Presequencing Products & Services
o Sequencing Services
o NGS Platforms
o Bioinformatics
o Services for NGS Platforms
· By Sequencing Type
o RNA Sequencing
o Whole Genome Sequencing
o Whole Exome Sequencing
o Targeted Resequencing
o CHIP Sequencing
o De Novo Sequencing
o Methyl Sequencing
o Others
· By Technology
o Sequencing by Synthesis
o Single-Molecule Real-Time Sequencing
o Nanopore Sequencing
o Ion Semiconductor Sequencing
o Others
· By Application
o Drug Discovery and Personalized Medicine
o Diagnostics
o Genetic Screening
o Agriculture and Animal Research
o Others
· By End-user
o Hospitals & Clinics
o Academic Institutes & Research Centers
o Pharmaceutical & Biotechnology Companies
o Others
· By Region
o North America
o South America
o Europe
o Asia-Pacific
o Middle East and Africa
Key Players Landscape and Outlook
Major entities in the global next-generation sequencing market actively seek partnerships to stimulate innovation and industry expansion. These alliances facilitate the exchange of resources, merging expertise and capitalizing on complementary strengths to pioneer advanced technologies and remedies. Collaborations among leading NGS firms bolster research capacities, hasten product advancement, and enhance market reach. Through combined resources, risk-sharing, and diverse viewpoints, these partnerships target intricate issues, elevate product portfolios, and establish stronger footholds in the competitive global next-generation sequencing market. Ultimately, they cultivate a more resilient and vibrant market environment, contributing to a dynamic industry ecosystem.
To help increase local access to NGS-based testing for patients with lung and breast cancer in more than 30 countries across Latin America, Africa, the Middle East, and Asia, where advanced genomic testing has previously been limited or unavailable, Pfizer and Thermo Fisher Scientific Inc. announced in May 2023 that they had entered into a collaboration agreement.
Key Players Operating in the Global Next-Generation Sequencing Market are:
· Illumina Inc.
· Thermo Fisher Scientific Inc.
· BGI Group
· Agilent Technologies, Inc.
· Qiagen N.V.
· Macrogen, Inc.
· Pacific Biosciences of California, Inc.
· Genewiz, LLC
· 10x Genomics, Inc.
· Oxford Nanopore Technologies plc
· F. Hoffmann-La Roche AG
Markets and Data report answers the following questions:
· What is the current and future market size of the product/service in question globally or specific to different countries?
· How are the markets divided into different product/service segments and the market size and growth of each segment?
· What is the market potential of different product segments and their investment case?
· How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
· What is the business environment and regulatory landscape specific to the product/service?
If you can't find what you're searching for or have any custom requirements for the global next-generation sequencing market, you may approach our team at info@marketsandata.com.
Table of Contents
1. Research Methodology
2. Project Scope & Definitions
3. Executive Summary
4. Global Next-Generation Sequencing Market Outlook, 2017-2031F
4.1. Market Size & Forecast
4.1.1.Value
4.1.2.Volume
4.2. By Product
4.2.1.NGS Consumables
4.2.2.Presequencing Products & Services
4.2.3.Sequencing Services
4.2.4.NGS Platforms
4.2.5.Bioinformatics
4.2.6.Services for NGS Platforms
4.3. By Sequencing Type
4.3.1.RNA Sequencing
4.3.2.Whole Genome Sequencing
4.3.3.Whole Exome Sequencing
4.3.4.Targeted Resequencing
4.3.5.CHIP Sequencing
4.3.6.De Novo Sequencing
4.3.7.Methyl Sequencing
4.3.8.Others
4.4. By Technology
4.4.1.Sequencing by Synthesis
4.4.2.Single-Molecule Real-Time Sequencing
4.4.3.Nanopore Sequencing
4.4.4.Ion Semiconductor Sequencing
4.4.5.Others
4.5. By Application
4.5.1.Drug Discovery and Personalized Medicine
4.5.2.Diagnostics
4.5.3.Genetic Screening
4.5.4.Agriculture and Animal Research
4.5.5.Others
4.6. By End-user
4.6.1.Hospitals & Clinics
4.6.2.Academic Institutes & Research Centers
4.6.3.Pharmaceutical & Biotechnology Companies
4.6.4.Others
4.7. By Region
4.7.1.North America
4.7.2.Europe
4.7.3.South America
4.7.4.Asia-Pacific
4.7.5.Middle East and Africa
4.8. By Company Market Share (%), 2023
5. Global Next-Generation Sequencing Market Outlook, By Region, 2017-2031F
5.1. North America*
5.1.1.Market Size & Forecast
5.1.1.1. Value
5.1.1.2. Volume
5.1.2.By Product Type
5.1.2.1. NGS Consumables
5.1.2.2. Presequencing Products & Services
5.1.2.3. Sequencing Services
5.1.2.4. NGS Platforms
5.1.2.5. Bioinformatics
5.1.2.6. Services for NGS Platforms
5.1.3.By Sequencing Type
5.1.3.1. RNA Sequencing
5.1.3.2. Whole Genome Sequencing
5.1.3.3. Whole Exome Sequencing
5.1.3.4. Targeted Resequencing
5.1.3.5. CHIP Sequencing
5.1.3.6. De Novo Sequencing
5.1.3.7. Methyl Sequencing
5.1.3.8. Others
5.1.4.By Technology
5.1.4.1. Sequencing by Synthesis
5.1.4.2. Single-Molecule Real-Time Sequencing
5.1.4.3. Nanopore Sequencing
5.1.4.4. Ion Semiconductor Sequencing
5.1.4.5. Others
5.1.5.By Application
5.1.5.1. Drug Discovery and Personalized Medicine
5.1.5.2. Diagnostics
5.1.5.3. Genetic Screening
5.1.5.4. Agriculture and Animal Research
5.1.5.5. Others
5.1.6.By End-user
5.1.6.1. Hospitals & Clinics
5.1.6.2. Academic Institutes & Research Centers
5.1.6.3. Pharmaceutical & Biotechnology Companies
5.1.6.4. Others
5.1.7.United States*
5.1.7.1. Market Size & Forecast
5.1.7.1.1. Value
5.1.7.1.2. Volume
5.1.7.2. By Product Type
5.1.7.2.1. NGS Consumables
5.1.7.2.2. Presequencing Products & Services
5.1.7.2.3. Sequencing Services
5.1.7.2.4. NGS Platforms
5.1.7.2.5. Bioinformatics
5.1.7.2.6. Services for NGS Platforms
5.1.7.3. By Sequencing Type
5.1.7.3.1. RNA Sequencing
5.1.7.3.2. Whole Genome Sequencing
5.1.7.3.3. Whole Exome Sequencing
5.1.7.3.4. Targeted Resequencing
5.1.7.3.5. CHIP Sequencing
5.1.7.3.6. De Novo Sequencing
5.1.7.3.7. Methyl Sequencing
5.1.7.3.8. Others
5.1.7.4. By Technology
5.1.7.4.1. Sequencing by Synthesis
5.1.7.4.2. Single-Molecule Real-Time Sequencing
5.1.7.4.3. Nanopore Sequencing
5.1.7.4.4. Ion Semiconductor Sequencing
5.1.7.4.5. Others
5.1.7.5. By Application
5.1.7.5.1. Drug Discovery and Personalized Medicine
5.1.7.5.2. Diagnostics
5.1.7.5.3. Genetic Screening
5.1.7.5.4. Agriculture and Animal Research
5.1.7.5.5. Others
5.1.7.6. By End-user
5.1.7.6.1. Hospitals & Clinics
5.1.7.6.2. Academic Institutes & Research Centers
5.1.7.6.3. Pharmaceutical & Biotechnology Companies
5.1.7.6.4. Others
5.1.8.Canada
5.1.9.Mexico
*All segments will be provided for all regions and countries covered
5.2. Europe
5.2.1.Germany
5.2.2.France
5.2.3.Italy
5.2.4.United Kingdom
5.2.5.Russia
5.2.6.Netherlands
5.2.7.Spain
5.2.8.Turkey
5.2.9.Poland
5.3. South America
5.3.1.Brazil
5.3.2.Argentina
5.4. Asia-Pacific
5.4.1.India
5.4.2.China
5.4.3.Japan
5.4.4.Australia
5.4.5.Vietnam
5.4.6.South Korea
5.4.7.Indonesia
5.4.8.Philippines
5.5. Middle East & Africa
5.5.1.Saudi Arabia
5.5.2.UAE
5.5.3.South Africa
6. Market Mapping, 2023
6.1. By Product
6.2. By Sequencing
6.3. By Technology
6.4. By Application
6.5. By End-user
6.6. By Region
7. Macro Environment and Industry Structure
7.1. Supply Demand Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
7.4.1.Political Factors
7.4.2.Economic System
7.4.3.Social Implications
7.4.4.Technological Advancements
7.4.5.Environmental Impacts
7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter’s Five Forces Analysis
7.5.1.Supplier Power
7.5.2.Buyer Power
7.5.3.Substitution Threat
7.5.4.Threat from New Entrant
7.5.5.Competitive Rivalry
8. Market Dynamics
8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)
9. Regulatory Framework and Innovation
9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies
10. Key Players Landscape
10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)
11. Pricing Analysis
12. Case Studies
13. Key Players Outlook
13.1.1. Company Details
13.1.2. Key Management Personnel
13.1.3. Products & Services
13.1.4. Financials (As reported)
13.1.5. Key Market Focus & Geographical Presence
13.1.6. Recent Developments
13.2. Thermo Fisher Scientific Inc.
13.3. BGI Group
13.4. Agilent Technologies, Inc.
13.5. Qiagen N.V.
13.6. Macrogen, Inc.
13.7. Pacific Biosciences of California, Inc.
13.8. Genewiz, LLC
13.9. 10x Genomics, Inc.
13.10. Oxford Nanopore Technologies plc
13.11. F. Hoffmann-La Roche AG
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
14. Strategic Recommendations
15. About Us & Disclaimer
List of Figures
Figure 1. Global Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 3. Global Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 4. Global Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 5. Global Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 6. Global Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 7. Global Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 8. Global Next-Generation Sequencing Market Share (%), By Region, 2017-2031F
Figure 9. North America Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 10. North America Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 11. North America Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 12. North America Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 13. North America Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 14. North America Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 15. North America Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 16. North America Next-Generation Sequencing Market Share (%), By Country, 2017-2031F
Figure 17. United States Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 18. United States Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 19. United States Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 20. United States Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 21. United States Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 22. United States Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 23. United States Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 24. Canada Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 25. Canada Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 26. Canada Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 27. Canada Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 28. Canada Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 29. Canada Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 30. Canada Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 31. Mexico Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 32. Mexico Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 33. Mexico Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 34. Mexico Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 35. Mexico Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 36. Mexico Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 37. Mexico Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 38. Europe Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 39. Europe Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 40. Europe Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 41. Europe Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 42. Europe Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 43. Europe Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 44. Europe Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 45. Europe Next-Generation Sequencing Market Share (%), By Country, 2017-2031F
Figure 46. Germany Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 47. Germany Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 48. Germany Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 49. Germany Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 50. Germany Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 51. Germany Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 52. Germany Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 53. France Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 54. France Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 55. France Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 56. France Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 57. France Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 58. France Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 59. France Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 60. Italy Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 61. Italy Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 62. Italy Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 63. Italy Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 64. Italy Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 65. Italy Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 66. Italy Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 67. United Kingdom Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 68. United Kingdom Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 69. United Kingdom Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 70. United Kingdom Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 71. United Kingdom Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 72. United Kingdom Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 73. United Kingdom Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 74. Russia Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 75. Russia Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 76. Russia Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 77. Russia Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 78. Russia Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 79. Russia Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 80. Russia Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 81. Netherlands Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 82. Netherlands Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 83. Netherlands Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 84. Netherlands Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 85. Netherlands Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 86. Netherlands Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 87. Netherlands Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 88. Spain Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 89. Spain Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 90. Spain Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 91. Spain Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 92. Spain Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 93. Spain Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 94. Spain Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 95. Turkey Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 96. Turkey Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 97. Turkey Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 98. Turkey Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 99. Turkey Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 100. Turkey Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 101. Turkey Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 102. Poland Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 103. Poland Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 104. Poland Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 105. Poland Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 106. Poland Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 107. Poland Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 108. Poland Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 109. South America Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 110. South America Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 111. South America Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 112. South America Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 113. South America Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 114. South America Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 115. South America Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 116. South America Next-Generation Sequencing Market Share (%), By Country, 2017-2031F
Figure 117. Brazil Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 118. Brazil Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 119. Brazil Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 120. Brazil Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 121. Brazil Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 122. Brazil Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 123. Brazil Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 124. Argentina Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 125. Argentina Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 126. Argentina Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 127. Argentina Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 128. Argentina Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 129. Argentina Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 130. Argentina Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 131. Asia-Pacific Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 132. Asia-Pacific Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 133. Asia-Pacific Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 134. Asia-Pacific Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 135. Asia-Pacific Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 136. Asia-Pacific Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 137. Asia- Pacific Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 138. Asia-Pacific Next-Generation Sequencing Market Share (%), By Country, 2017-2031F
Figure 139. India Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 140. India Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 141. India Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 142. India Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 143. India Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 144. India Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 145. India Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 146. China Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 147. China Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 148. China Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 149. China Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 150. China Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 151. China Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 152. China Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 153. Japan Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 154. Japan Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 155. Japan Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 156. Japan Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 157. Japan Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 158. Japan Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 159. Japan Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 160. Australia Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 161. Australia Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 162. Australia Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 163. Australia Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 164. Australia Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 165. Australia Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 166. Australia Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 167. Vietnam Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 168. Vietnam Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 169. Vietnam Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 170. Vietnam Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 171. Vietnam Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 172. Vietnam Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 173. Vietnam Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 174. South Korea Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 175. South Korea Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 176. South Korea Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 177. South Korea Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 178. South Korea Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 179. South Korea Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 180. South Korea Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 181. Indonesia Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 182. Indonesia Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 183. Indonesia Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 184. Indonesia Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 185. Indonesia Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 186. Indonesia Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 187. Indonesia Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 188. Philippines Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 189. Philippines Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 190. Philippines Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 191. Philippines Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 192. Philippines Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 193. Philippines Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 194. Philippines Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 195. Middle East & Africa Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 196. Middle East & Africa Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 197. Middle East & Africa Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 198. Middle East & Africa Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 199. Middle East & Africa Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 200. Middle East & Africa Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 201. Middle East & Africa Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 202. Middle East & Africa Next-Generation Sequencing Market Share (%), By Country, 2017-2031F
Figure 203. Saudi Arabia Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 204. Saudi Arabia Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 205. Saudi Arabia Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 206. Saudi Arabia Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 207. Saudi Arabia Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 208. Saudi Arabia Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 209. Saudi Arabia Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 210. UAE Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 211. UAE Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 212. UAE Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 213. UAE Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 214. UAE Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 215. UAE Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 216. UAE Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 217. South Africa Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
Figure 218. South Africa Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
Figure 219. South Africa Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
Figure 220. South Africa Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
Figure 221. South Africa Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
Figure 222. South Africa Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
Figure 223. South Africa Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
Figure 224. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 225. By Sequencing Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 226. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 227. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 228. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
List of Tables
Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
Frequently Asked Questions
Who are the key players operating in the global next-generation sequencing market?
What are the regions covered in the final report for global next-generation sequencing market?
What is the market size and growth rate of the global next-generation sequencing market?
What are the major factors influencing the growth of the global next-generation sequencing market?
See Related Reports
Global Bone Densitometers Market Assessment, Opportunities and Forecast, 2017-2031F
There is an increased demand for dual-energy x-ray absorptiometry (DXA) in the global bone densitometers market. Also, increasing prevalence of osteoporosis, growing geriatric population, technological advancements, and collaborative research and new....Read More
Published on
May 2024
4,500
Global Medical Terminology Software Market Assessment, Opportunities and Forecast, 2017-2031F
Global medical terminology software market is expected to witness significant growth over the forecast period owing to an increase in measures for reducing clinical errors and rising investments towards the development of technologically advanced sol....Read More
Published on
May 2024
4,500
Global Legionella Testing Market Assessment, Opportunities and Forecast, 2017-2031F
Global legionella testing market will witness significant growth owing to the rapid expansion of the healthcare sector, increasing awareness about the importance of regular legionella testing, and rising prevalence of legionella related illnesses.....Read More
Published on
May 2024
4,500
Global Endoluminal Suturing Devices Market Assessment, Opportunities and Forecast, 2017-2031F
Global endoluminal suturing devices market is expected to witness significant growth over the forecast period owing to rise in the number of cases of gastrointestinal cancer and increasing preference for non-invasive procedures.....Read More
Published on
May 2024
4,500
Purchase Options
USD ($)
i
3,000
i
4,500
i
5,700
i
8,200
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US
